UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence
The company will reinforce its position as an Experience Optimization leader, significantly expanding its product feature management capabilities to help businesses deliver “Amazon-Like” experiences.